Three Months Aerobic Training Cannot Modulate C-Terminal Telopeptide of Type 1 Collagen in Cigarette Smokers

authors:

avatar Mojtaba Eizadi 1 , avatar Davood Khorshidi 1 , *

Department of Exercise Physiology, Saveh Branch, Islamic Azad University, Saveh, Iran

how to cite: Eizadi M, Khorshidi D. Three Months Aerobic Training Cannot Modulate C-Terminal Telopeptide of Type 1 Collagen in Cigarette Smokers. Jundishapur J Chronic Dis Care. 2019;8(2):e62047. https://doi.org/10.5812/jjcdc.62047.

Abstract

Background:

Osteoporosis, as an important public health problem, is associated with cigarette smoking.

Objectives:

The present study aimed to evaluate the impact of 3 months supervised aerobic training program on C-terminal telopeptide of type 1 collagen (CTX) as a marker of bone resorption in male smokers.

Methods:

In this semi-experimental study, thirty-two sedentary adult male smokers (Winter 2016, Saveh, Iran) aged 42 ± 7 years were randomly assigned to exercise group (3 months aerobic training, 3 times/weekly at 60% - 75% of maximum heart rate, n = 16) or control group (no training, n = 16). Serum calcium, CTX and anthropometrical markers at before and after training were determined in exercise and control subjects. The statistical significance of the changes was evaluated by Student’s t-test. The changes less than 0.05 were considered statistically significant.

Results:

A significant decrease was observed in anthropometrical markers by aerobic training in the exercise group (P < 0.05). No significant changes were observed for serum calcium (P = 0.126) and CTX (P = 0.835) after aerobic intervention compared with baseline levels. No significant changes were observed in all variables in the control group (P ≥ 0.05).

Conclusions:

These data suggest that aerobic training with mentioned details cannot improve bone resorption with emphasis on CTX in male smokers. To achieve a better conclusion, it is necessary to assess the indicative markers of both bone resorption and formation in response to exercise.

1. Background

Bone remodeling is achieved via bone resorption by osteoclast cells on one side and the formation of new bone by osteoblast cells on the other side; which is continued during life (1, 2). The increase in bone resorption markers such as C-terminal telopeptide of type 1 collagen (CTX), pyridinoline, and hydroxyproline and the decrease in biochemical markers of bone formation such as alkaline phosphatase and osteocalcin are associated with osteoporosis or bone destruction (2). This process is associated with aging by gradually decreasing bone mass and osteoporosis (3). However, several factors of clinical disorders such as hyperthyroidism digestive disorders, genetics, lack of mobility, physical inactivity, and increased serum cortisol affect this phenomenon (4).

On the other hand, cigarette smoking reduces the absorption of calcium, which is a determinant of bone formation (5). Smoking reduces the density of minerals, the absorption of calcium along with hyperparathyroidism while increases bone resorption. Also, the findings of a study on twin females showed that those who consumed more cigarettes had lower levels of bone density compared with those who had less cigarette smoking (6). In this regard, the findings of some studies indicated that osteocalcin concentration, as a marker of bone formation, was decreased in female smokers (7). Some findings also suggest that levels of CTX and dihydroxyproline, which are the main characteristics of bone resorption or formation, are higher in smokers than non-smokers (8).

These studies suggest that, even after matching for age and body weight, smokers have a lower bone density than non-smokers (9). Hence, the creation of appropriate strategies to prevent or reduce osteoporosis in smokers is at the heart of the attention of health researchers. Physical activity, in this regard, is one of the important determinants of bone mass and its role in the skeletal tissue and the bone mass increase has been numerously reported. As bone mass is decreased in smokers, the increase in strength and physical activity is associated with more bone mass (10). Although the role of exercise and physical activity on bone metabolism as well as bone marker indices in smokers have been less studied, several studies have been conducted on healthy and sick non-smoker populations, which are often contradictory and inconsistent. For example, in the study conducted by Evans et al. (11), 9 months of moderate aerobic training with moderate intensity led to a reduction in serum CTX levels without alteration in alkaline phosphatase in postmenopausal females. In contrast, in another study, Tosun et al. (12), there was no change in osteocalcin and other indicators of bone formation and bone resorption following exercise in healthy females. Also, some studies Courteix et al. (13) and Jaffre et al. (14) have pointed out higher levels and normal levels (15) of bone destruction indicators such as CTX in female athletes. Another study demonstrated that in sports such as volleyball and basketball that are weight-bearing, bone formation, and bone density are much higher than sports that are not weight-bearing (16). A review of the available pieces of evidence suggests a contradiction in the response or compatibility of bone-marker indices in healthy and patient populations. On the other hand, the type of population studied and other factors, including exercise intensity, type of exercise protocol such as strength or endurance (17), and the number of exercise sessions (18) are of special importance on how exercise activity affects bone remodeling in both healthy and patient populations.

Given the contradictory evidence about the role of exercise and physical activity depending on intensity, frequency or duration of training protocol on bone metabolism, as well increasingly cigarette smoking among males in our country and its relation with osteoporosis, our study was conducted with the mentioned aims. On the other hand, most studies in this area have been done on females and there are limited studies on inactive males with cigarette smokers particularly in our country.

2. Objectives

The present study aimed to assess the effect of 12 weeks of aerobic training program on serum CTX levels as one of the most important indicators of bone resorption as well as on serum calcium levels in sedentary adult male smokers.

3. Methods

3.1. Human Subjects

The participants were comprised of thirty-two sedentary adult male smokers that matched for sex (males), age (42 ± 7, aged), and weight (94 ± 10 kg) that participated in study by convenience and purposive sampling and selected to either exercise group (3 months aerobic training, 3 times/weekly at 60% - 75% of maximum heart rate, n = 16) or control group (no exercise, n = 16) based on random sampling using a table of random numbers (Winter 2016, Saveh, Iran). The study protocol was approved by the Ethics Committee of Islamic Azad University, Saveh branch, Iran. After the nature of the study was explained in details, informed consent was obtained from all subjects.

3.2. Inclusion Criteria

The main inclusion criteria for participation in this study were cigarette smoking at least for 3 years, non-athletes and non-alcoholic. The participants had not previously regular exercise or any previous participation in weight loss programs (at least during the last 6 months). None of the participants used medication therapies for osteoporosis or other disorders, and none of them had an injury history that would prevent exercise (19).

3.3. Exclusion Criteria

Those with a history of chronic diseases (asthma, metabolic syndrome, diabetes, cardiovascular or other diseases) were also excluded from the study (19).

3.4. Anthropometry

Height and body weight were measured to the nearest 0.1 kg and the nearest 0.1 cm, respectively on the same day. The BMI was calculated as the weight (kilograms) divided by the square of the height (meters). Hip and abdominal circumferences were measured in the most condensed part. Body fat (%) and visceral fat were measured using a body composition monitor (OMRON, Finland). Each measurement was conducted 3 times and the average was recorded.

3.5. Exercise Program

Aerobic training lasted 3 months as three sessions weekly, consisting of a warm-up then a 45 - 60-minutes treadmill exercise at 60% - 80% HRmax followed by a 5 - 10 minutes cooling-down. In each session, the main exercise was running with no slope ((20), Modified). The heart rate was determined by polar telemetry to calculate the exercise intensity. At the first week, the exercise intensity was 60% HRmax that gradually was increased to 80% HRmax at last week of the training program. Control subjects were instructed to maintain their habitual activities throughout the study. All participants were instructed to maintain their usual diet throughout the study.

3.6. Blood Analyses

Blood samples were obtained before of training program and 48 h after last exercise session with regard to measuring calcium and CTX of all subjects. Samples were taken following a 10 - 12 overnight fast between 8:00 A.M. - 9:00 A.M. All participants were banned any heavy physical activity for 48 hours before sampling. To separate serum, samples were dispensed into EDTA-coated tubes and centrifuged, then aliquots were stored at -80ºC until biochemical analyses. The ELISA method (enzyme-linked immunosorbent assay for quantitative detection of human CTX, Biovendor, Austria) was used to measuring serum CTX. The inter and intra-assay coefficients of variance and sensitivity of the test were 3.0%, 10.9%, and 40 mg/mL, respectively. Serum calcium was analyzed by a chemical colorimetric method using spectrophotometer (Biochemistry Company, Iran).

3.7. Statistical Methods

All statistical analyses were performed using SPSS (version 16 .0; SPSS Inc, Chicago, IL, USA). Given the normal distribution of the data, which was analyzed by Kolmogorov-Smirnov normality test, subsequent analysis was independent and paired sample t-test. At baseline, independent t-test was used to compare all variables between the two groups. Pre- and post-training differences of all variable were assessed by paired t-test in each group. The changes less than 0.05 were considered statistically significant.

4. Results

In the present study, we aimed to assess the impact of 3 months aerobic training on CTX as a resorption bone marker and calcium in male smokers. Pre- (baseline) and post-training anthropometrical markers of the groups are shown in Table 1. There were no statistically significant differences between the exercise and control subjects with regard to the anthropometrical indices at baseline (P > 0.05). The aerobic intervention resulted in significant decreases in weight (P = 0.000, Figure 1), body fat percentage (P = 0.000, Figure 2), and the other anthropometrical indices in the exercise group compared with the control subjects (Table 1).

Table 1.

Mean and SD of Anthropometrical Markers Before and After Training Program in Groups

VariablesExercise GroupControl Group
Pre-TrainingPost-TrainingP ValuePre-TrainingPost-TrainingP Value
Age, y41.6 ± 7.3941.6 ± 7.39-42.1 ± 2.8142.1 ± 2.81-
Height, cm175 ± 4.4175 ± 4.4-175 ± 3.6175 ± 3.6-
Weight, kg94.6 ± 6.2591.4 ± 6.500.00094.7 ± 9.7993.9 ± 9.810.433
AC, cm106 ± 6.3101.8 ± 5.670.000105 ± 7.9104.6 ± 8.250.362
HC, cm105 ± 2.49100.7 ± 2.490.000104 ± 6.13104.1 ± 6.300.562
Body fat, %29.6 ± 2.4428.4 ± 2.160.00030.4 ± 2.7330.3 ± 2.890.463
BMI, kg/m230.9 ± 2.4129.8 ± 2.420.00030.7 ± 2.5930.6 ± 2.670.384
Pre- and post-training of body weight in the studied groups. Aerobic intervention resulted in a significant decrease in body weight in the exercise subjects. However, this variable showed no change in the control subjects.
Pre- and post-training of body weight in the studied groups. Aerobic intervention resulted in a significant decrease in body weight in the exercise subjects. However, this variable showed no change in the control subjects.
Pre- and post-training of body fat percentage in the studied groups. Aerobic intervention resulted in a significant decrease in body fat in the exercise subjects. However, this variable showed no change in the control subjects.
Pre- and post-training of body fat percentage in the studied groups. Aerobic intervention resulted in a significant decrease in body fat in the exercise subjects. However, this variable showed no change in the control subjects.

Table 2 represents the pre- and post-training circulating levels of CTX and calcium of the two groups. Based on independent t-test, significant differences were not observed in these variables between the groups at the baseline level (P > 0.05).

The effect of aerobic training on serum CTX was the main aim of the present study. Data by paired sample t-test showed no significant difference between pre- and post-training values in serum CTX of the exercise subjects (P = 0.835, Figure 3). No significant difference was also found in calcium concentration by aerobic intervention in comparison to baseline level in the exercise subjects (P = 0.126, Figure 4). There were no changes in variables in the control group (P > 0.05).

Table 2.

Circulation Level of Serum Osteocalcin and ALP Activity at Pre- and Post-Training in Groups (Mean ± SD)

VariablesExercise GroupControl Group
Pre-TrainingPost-TrainingP ValuePre-TrainingPost-TrainingP Value
CTX, U/L0.444 ± 0.2020.446 ± 0.2090.8350.414 ± 0.0910.428 ± 0.0760.905
Calcium, mg/dL9.71 ± 0.4710.08 ± 0.510.1269.56 ± 0.149.52 ± 0.140.486
Pre- and post-training of serum CTX in the studied groups. No significant change was observed in serum CTX by aerobic intervention in the exercise subjects.
Pre- and post-training of serum CTX in the studied groups. No significant change was observed in serum CTX by aerobic intervention in the exercise subjects.
Pre- and post-training of serum calcium in studied groups. No significant change was observed in calcium by aerobic intervention in the exercise subjects.
Pre- and post-training of serum calcium in studied groups. No significant change was observed in calcium by aerobic intervention in the exercise subjects.

5. Discussion

No significant change in serum CTX between the two groups is the main finding of this study. In other words, 12 weeks of aerobic training, 3 sessions per week did not lead to significant changes in CTX levels in adult male smokers. In addition, calcium levels did not change significantly in response to training intervention. The lack of difference in these variables in smokers is reported while the research background on the response or compatibility of these bone markers in smokers is limited. However, the findings of other studies in response to exercise training in non-smoker populations are somewhat contradictory. For example, in a recent study by Toriola et al. (21), a weight loss program of 6 and 12 months in the form of diet modification and exercise training was associated with lack of CTX change in obese or overweight females with breast cancer. In another study Szulc et al. (8), 6 months aerobic exercise, 3 sessions per week, did not significantly change in alkaline phosphatase and calcium levels in middle-aged females. However, in the study by Kilebrant et al. (22), 6 months of total body vibration (42 - 40 Hz, 15 - 5 min), two sessions per week, to strengthen bone mass markers and bone turnover of 5 to 16 years old children with mental disability, resulted in a significant decrease in CTX compared with the baseline levels. Likewise, in a study by Evans et al. (11), 9 months of moderate-intensity aerobic training led to a reduction in serum CTX levels in postmenopausal females. Ghasemalipour et al. (19) reported a significant decrease in serum CTX by 3 month-aerobic training in adult males with mild to moderate asthma.

CTX has been introduced as an osteoclast-derived bone destruction marker, and its increase alongside the fixed levels of osteocalcin is a marker of bone destruction (23). On the other hand, scientific sources refer to impaired bone formation markers or bone destruction in smokers (6). In other words, the increase in nicotine induced by smoking is associated with impaired bone metabolism (8). In this regard, it has been shown that nicotine affects the formation of bone due to the damage to the signaling pathways and metabolism associated with the extracellular matrix (24). It has also been reported that Gao et al. (25) the exposure of male Wistar rats to cigarette smoke for 4 months, due to an increase in the levels of osteoclasts and decreased volume of bone connective tissue, the number and thickness of the connective tissue bands, the rate of bone formation, and the reconstruction of osteoblasts reduced the process of bone turnover. The increase in reactive oxygen species and free radicals due to smoking is also associated with the inhibition of the formation of osteoblasts in the bone surface (26). The adverse effects of cigarette smoking and its cessation on the prevalence of osteoporosis have also been reported by some other studies (27-29). Smoke-induced hypercortisolism, which has been reported frequently, directly affects osteoblasts, osteoclasts, and bone metabolism. The increase in cortisol in response to cigarette smoking is also associated with impairment of calcium reabsorption from the digestive system and kidney tubules (30).

The process of bone formation or destruction does not depend solely on changes in CTX or osteocalcin as indicators of bone destruction or formation. It is an outcome of osteocalcin and CTX changes that determine bone formation or degradation. The increase in the ratio of osteocalcin to CTX has also been shown to improve the profile of bone formation (31). In fact, an increase in the ratio of formation markers to bone destruction markers has been shown to be an indicator of the beneficial effects of therapeutic stimulants on bone turnover. In the study by Karabulut et al. (32), 6 weeks of low intensity and intense resistance training led to an increase in the ratio of alkaline phosphatase to CTX in elderly people. It should be noted that similar to osteocalcin, alkaline phosphatase is also an indicator of bone formation. Also, the beneficial effects of exercise depend on the type of exercise program and the studied population. In a recent study, muscular contractions in the form of vibration in children aged from 5 to 16 years with a mental disability led to a significant decrease in CTX and a significant increase in osteocalcin compared with baseline levels (22). Researchers have also noted the beneficial effects of exercise in combination with some effective stimuli on bone formation processes. For example, in the study by Jiang et al. (33), the combination of 12 months of aerobic exercise with statin resulted in CTX reduction in participants with metabolic syndrome. Also, in a recent study by Achiou et al. (34), daily aerobic exercise plus the use of sclerostine antibody for 9 weeks increased the markers of bone formation, such as osteocalcin, and prevented destructive effects of glucocorticoids on bone mineral density, including bone mineral capacity, bone density, and the volume of bone mass connective tissue in male Wistar rats injected with glucocorticosteroids. Sun et al. (35), also revealed that regular aerobic exercises combined with Naringin for 60 days led to an increase in the osteocalcin expression and a reduction in CTX-1 type I in male Wistar rats. Researchers believe that the effects of exercise training on the bone are particularly dependent on the intensity and duration of the exercise; the intensity or load on the bone is more important than the exercise time (36). Also, low-intensity exercise programs cannot prevent osteoporosis. Furthermore, high-intensity exercises are possibly associated with a reduction in the thickness of the trabecular and cortical bones (34). The unchanged levels of CTX and calcium in the present study may be attributed to the moderate intensity of aerobic training; however, the small number of samples, which is a limitation of the current study, might also be in some way the reason for the insignificant findings. In addition, no response measurement of other bone metabolism markers such as osteocalcin, alkaline phosphatase, calcitonin, and parathyroid hormone are the other limitations of this study. Determining the therapeutic effects of exercise training on bone metabolism and prevention of osteoporosis in smokers are remarkable outcomes from a clinical perspective.

5.1. Conclusions

Despite the beneficial effects of exercise training on bone metabolism reported by some previous studies, the level of calcium and CTX remained without change by 3 months aerobic training in our study. It is likely aerobic training affected other bone metabolism determinatives such as PTH, osteocalcin, and alkaline phosphatase as bone formation markers. Therefore, further studies are necessary to elucidate the therapeutic and clinical significance of aerobic training in bone metabolism in smokers and other populations.

Acknowledgements

References

  • 1.

    Confavreux CB, Levine RL, Karsenty G. A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol. 2009;310(1-2):21-9. [PubMed ID: 19376193]. [PubMed Central ID: PMC3667507]. https://doi.org/10.1016/j.mce.2009.04.004.

  • 2.

    Achemlal L, Tellal S, Rkiouak F, Nouijai A, Bezza A, Derouiche el M, et al. Bone metabolism in male patients with type 2 diabetes. Clin Rheumatol. 2005;24(5):493-6. [PubMed ID: 15747054]. https://doi.org/10.1007/s10067-004-1070-9.

  • 3.

    Berarducci A. Osteoporosis education. A health-promotion mandate for nurses. Orthop Nurs. 2004;23(2):118-20. [PubMed ID: 15103797].

  • 4.

    Stein E, Shane E. Secondary osteoporosis. Endocrinol Metab Clin North Am. 2003;32(1):115-34. vii. [PubMed ID: 12699295].

  • 5.

    Krall EA, Dawson-Hughes B. Smoking increases bone loss and decreases intestinal calcium absorption. J Bone Miner Res. 1999;14(2):215-20. [PubMed ID: 9933475]. https://doi.org/10.1359/jbmr.1999.14.2.215.

  • 6.

    Hopper JL, Seeman E. The bone density of female twins discordant for tobacco use. N Engl J Med. 1994;330(6):387-92. [PubMed ID: 8284003]. https://doi.org/10.1056/NEJM199402103300603.

  • 7.

    Hermann AP, Brot C, Gram J, Kolthoff N, Mosekilde L. Premenopausal smoking and bone density in 2015 perimenopausal women. J Bone Miner Res. 2000;15(4):780-7. [PubMed ID: 10780870]. https://doi.org/10.1359/jbmr.2000.15.4.780.

  • 8.

    Szulc P, Garnero P, Claustrat B, Marchand F, Duboeuf F, Delmas PD. Increased bone resorption in moderate smokers with low body weight: The Minos study. J Clin Endocrinol Metab. 2002;87(2):666-74. [PubMed ID: 11836302]. https://doi.org/10.1210/jcem.87.2.8232.

  • 9.

    Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int. 2001;68(5):259-70. [PubMed ID: 11683532]. [PubMed Central ID: PMC5352985].

  • 10.

    Kolbe-Alexander TL, Charlton KE, Lambert EV. Lifetime physical activity and determinants of estimated bone mineral density using calcaneal ultrasound in older South African adults. J Nutr Health Aging. 2004;8(6):521-30. [PubMed ID: 15543427].

  • 11.

    Evans EM, Racette SB, Van Pelt RE, Peterson LR, Villareal DT. Effects of soy protein isolate and moderate exercise on bone turnover and bone mineral density in postmenopausal women. Menopause. 2007;14(3 Pt 1):481-8. [PubMed ID: 17213752]. [PubMed Central ID: PMC2366994]. https://doi.org/10.1097/01.gme.0000243570.78570.f7.

  • 12.

    Tosun A, Bolukbasi N, Cingi E, Beyazova M, Unlu M. Acute effects of a single session of aerobic exercise with or without weight-lifting on bone turnover in healthy young women. Mod Rheumatol. 2006;16(5):300-4. [PubMed ID: 17039311]. https://doi.org/10.1007/s10165-006-0503-5.

  • 13.

    Courteix D, Rieth N, Thomas T, Van Praagh E, Benhamou CL, Collomp K, et al. Preserved bone health in adolescent elite rhythmic gymnasts despite hypoleptinemia. Horm Res. 2007;68(1):20-7. [PubMed ID: 17220634]. https://doi.org/10.1159/000098546.

  • 14.

    Jaffre C, Courteix D, Dine G, Lac G, Delamarche P, Benhamou L. High-impact loading training induces bone hyperresorption activity in young elite female gymnasts. J Pediatr Endocrinol Metab. 2001;14(1):75-83. [PubMed ID: 11220709].

  • 15.

    Lehtonen-Veromaa M, Mottonen T, Irjala K, Nuotio I, Leino A, Viikari J. A 1-year prospective study on the relationship between physical activity, markers of bone metabolism, and bone acquisition in peripubertal girls. J Clin Endocrinol Metab. 2000;85(10):3726-32. [PubMed ID: 11061531]. https://doi.org/10.1210/jcem.85.10.6889.

  • 16.

    Creighton DL, Morgan AL, Boardley D, Brolinson PG. Weight-bearing exercise and markers of bone turnover in female athletes. J Appl Physiol (1985). 2001;90(2):565-70. [PubMed ID: 11160054]. https://doi.org/10.1152/jappl.2001.90.2.565.

  • 17.

    Woitge HW, Friedmann B, Suttner S, Farahmand I, Muller M, Schmidt-Gayk H, et al. Changes in bone turnover induced by aerobic and anaerobic exercise in young males. J Bone Miner Res. 1998;13(12):1797-804. [PubMed ID: 9844096]. https://doi.org/10.1359/jbmr.1998.13.12.1797.

  • 18.

    Karlsson KM, Karlsson C, Ahlborg HG, Valdimarsson O, Ljunghall S. The duration of exercise as a regulator of bone turnover. Calcif Tissue Int. 2003;73(4):350-5. [PubMed ID: 12874708]. https://doi.org/10.1007/s00223-002-0003-3.

  • 19.

    Ghasemalipour H, Eizadi M, Dadgan MH, Shakeri N. [Therapeutic effect of aerobic training on cross-linked telopeptides of type I collagen (CTX) as bone reasorption indicative in obese male with mild to moderate asthma]. Armaghane Danesh. 2017;22(2):189-204. Persian.

  • 20.

    Eizadi M, Karimy M, Kohandel M, Doaly H. [Effect of aerobic exercise on serum leptin response and insulin resistance of patients with type 2 diabetes]. J Qazvin Univ Med Sci. 2013;16(4):33-9. Persian.

  • 21.

    Toriola AT, Liu J, Ganz PA, Colditz GA, Yang L, Izadi S, et al. Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors. Breast Cancer Res Treat. 2015;152(3):637-43. [PubMed ID: 26175059]. [PubMed Central ID: PMC4521978]. https://doi.org/10.1007/s10549-015-3496-y.

  • 22.

    Kilebrant S, Braathen G, Emilsson R, Glansen U, Soderpalm AC, Zetterlund B, et al. Whole-body vibration therapy in children with severe motor disabilities. J Rehabil Med. 2015;47(3):223-8. [PubMed ID: 25613047]. https://doi.org/10.2340/16501977-1921.

  • 23.

    Molenaar ET, Lems WF, Dijkmans BA, de Koning MH, van de Stadt RJ, Voskuyl AE. Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis. Rheumatology (Oxford). 2000;39(7):742-4. [PubMed ID: 10908692].

  • 24.

    Marinucci L, Bodo M, Balloni S, Locci P, Baroni T. Sub-toxic nicotine concentrations affect extracellular matrix and growth factor signaling gene expressions in human osteoblasts. J Cell Physiol. 2014;229(12):2038-48. [PubMed ID: 24777817]. https://doi.org/10.1002/jcp.24661.

  • 25.

    Gao SG, Cheng L, Li KH, Liu WH, Xu M, Jiang W, et al. Effect of epimedium pubescen flavonoid on bone mineral status and bone turnover in male rats chronically exposed to cigarette smoke. BMC Musculoskelet Disord. 2012;13:105. [PubMed ID: 22713117]. [PubMed Central ID: PMC3480917]. https://doi.org/10.1186/1471-2474-13-105.

  • 26.

    Holzer N, Braun KF, Ehnert S, Egana JT, Schenck TL, Buchholz A, et al. Green tea protects human osteoblasts from cigarette smoke-induced injury: Possible clinical implication. Langenbecks Arch Surg. 2012;397(3):467-74. [PubMed ID: 22160325]. https://doi.org/10.1007/s00423-011-0882-8.

  • 27.

    Trevisan C, Klumpp R, Compagnoni R. Risk factors in transient osteoporosis: A retrospective study on 23 cases. Clin Rheumatol. 2016;35(10):2517-22. [PubMed ID: 26979746]. https://doi.org/10.1007/s10067-016-3228-7.

  • 28.

    Ugurlu U, Nayki U, Nayki C, Ulug P, Kulhan M, Yildirim Y. Assessment of smoking for low bone mineral density in postmenopausal Turkish women. Wien Klin Wochenschr. 2016;128(3-4):114-9. [PubMed ID: 26438103]. https://doi.org/10.1007/s00508-015-0867-7.

  • 29.

    Shen GS, Li Y, Zhao G, Zhou HB, Xie ZG, Xu W, et al. Cigarette smoking and risk of hip fracture in women: A meta-analysis of prospective cohort studies. Injury. 2015;46(7):1333-40. [PubMed ID: 25956674]. https://doi.org/10.1016/j.injury.2015.04.008.

  • 30.

    Yoon V, Maalouf NM, Sakhaee K. The effects of smoking on bone metabolism. Osteoporos Int. 2012;23(8):2081-92. [PubMed ID: 22349964]. https://doi.org/10.1007/s00198-012-1940-y.

  • 31.

    Golabek K, Ostrowska Z, Ziora K, Oswiecimska J, Swietochowska E, Marek B, et al. Association between omentin-1, bone metabolism markers, and cytokines of the RANKL/RANK/OPG system in girls with anorexia nervosa. Endokrynol Pol. 2015;66(6):514-20. [PubMed ID: 26662650]. https://doi.org/10.5603/EP.2015.0063.

  • 32.

    Karabulut M, Bemben DA, Sherk VD, Anderson MA, Abe T, Bemben MG. Effects of high-intensity resistance training and low-intensity resistance training with vascular restriction on bone markers in older men. Eur J Appl Physiol. 2011;111(8):1659-67. [PubMed ID: 21207053]. https://doi.org/10.1007/s00421-010-1796-9.

  • 33.

    Jiang J, Boyle LJ, Mikus CR, Oberlin DJ, Fletcher JA, Thyfault JP, et al. The effects of improved metabolic risk factors on bone turnover markers after 12 weeks of simvastatin treatment with or without exercise. Metabolism. 2014;63(11):1398-408. [PubMed ID: 25151031]. https://doi.org/10.1016/j.metabol.2014.07.011.

  • 34.

    Achiou Z, Toumi H, Touvier J, Boudenot A, Uzbekov R, Ominsky MS, et al. Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia. Bone. 2015;81:691-701. [PubMed ID: 26409255]. https://doi.org/10.1016/j.bone.2015.09.010.

  • 35.

    Sun X, Li F, Ma X, Ma J, Zhao B, Zhang Y, et al. The effects of combined treatment with naringin and treadmill exercise on osteoporosis in ovariectomized rats. Sci Rep. 2015;5:13009. [PubMed ID: 26260240]. [PubMed Central ID: PMC4531319]. https://doi.org/10.1038/srep13009.

  • 36.

    Tromp AM, Bravenboer N, Tanck E, Oostlander A, Holzmann PJ, Kostense PJ, et al. Additional weight bearing during exercise and estrogen in the rat: The effect on bone mass, turnover, and structure. Calcif Tissue Int. 2006;79(6):404-15. [PubMed ID: 17160577]. https://doi.org/10.1007/s00223-006-0045-z.